Vivani Medical VANI Biopharm Division — Other General And Administrative Expense

Other segment segments

Similar metrics at other companies

ANABBiopharma Company — General And Administrative Expense

$18.86M+92.1%

SNDXBiopharmaceutical Cancer Therapeutics — Other General And Administrative Expense

$5.14M+16.5%

VCYTBiopharmaceutical and other revenue — Other cost

$8K-99.2%

LHBiopharma Laboratory Services — Other Cost and Expense, Operating

$89.7M-0.3%

PFEBiopharma — Selling, informational and administrative expenses

$2.13B-2.5%

AEIBiohealth Business — Other General Expense

$97.62K-81.0%

Questions, answered.

What is Vivani Medical's biopharm division — other general and administrative expense?

Vivani Medical (VANI) reported biopharm division — other general and administrative expense of $287K in Q1 2026.

How has Vivani Medical's biopharm division — other general and administrative expense changed year-over-year?

Vivani Medical's biopharm division — other general and administrative expense increased by 77.2% year-over-year, from $162K to $287K.

What is the long-term trend for Vivani Medical's biopharm division — other general and administrative expense?

Over 2 years (2023 to 2025), Vivani Medical's biopharm division — other general and administrative expense has grown at a -8.9% compound annual growth rate (CAGR), from $945K to $784K.

What does biopharm division — other general and administrative expense mean?

Includes miscellaneous overhead costs not categorized under direct research or labor, such as office supplies, utilities, and general administrative support for the biopharmaceutical segment. This metric captures the baseline operational friction of running the business unit. Tracking this helps identify potential cost-saving opportunities in non-core activities.